A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer

Author： Oh Sung Yong   Kwon Hyuk-Chan   Seo Bong-Gun   Kim Sung-Hyun   Kim Jae-Seok   Kim Hyo-Jin  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.46, Iss.3, 2007-01, pp. : 336-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

By                          

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 425-428

Spandidos Publications

Access to resources Recommend Favorite

A Phase II Trial of Oxaliplatin, Folinic Acid, and 5-Fluorouracil (FOLFOX4) as First-Line Chemotherapy in Advanced Colorectal Cancer: A China Single-Center Experience

By Xu Nong   Fang Wei-Jia   Zhang Xiao-Chen   Yu Lan-Fang   Bao Han-Ying   Shi Gen-Ming   Huang Sui   Shen Peng  

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

By Zhu Xiaodong   Leaw Jiin   Gu Weilie   Qian Yiying   Du Hongyu   Wang Biyun   Hong Xiaonan   Yin Jiliang  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 929-936

Springer Publishing Company

Access to resources Recommend Favorite

Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience

By Shimizu Toshio   Satoh Taroh   Tamura Kenji   Ozaki Tomohiro   Okamoto Isamu   Fukuoka Masahiro   Nakagawa Kazuhiko  

International Journal of Clinical Oncology, Vol. 12, Iss. 3, 2007-06 ,pp. : 218-223

Springer Publishing Company

Access to resources Recommend Favorite

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

By Maindrault-Goebel F.   de Gramont A.   Louvet C.   Andre T.   Carola E.   Mabro M.   Artru P.   Gilles V.   Lotz J.P.   Izrael V.   Krulik M.   for the Oncology Multidisciplinary Research Group GERCOR  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 1000-1005

Elsevier

Access to resources Recommend Favorite